Condition
Castration Resistant Prostatic Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Castration Resistant Prostatic Cancer clinical trials that are recruiting, at sites in 19 countries (most in United States (4), Australia (3), United Kingdom (2)). By phase: Phase 1 (3), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 19Countries
Newest Castration Resistant Prostatic Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ifinatamab deruxtecan alone or with other drugs for metastatic castration‑resistant prostate cancer | Phase 1/2 | Los Angeles, California and 81 other locations | Recruiting | Mar 7, 2025 |
| Testing MGC026 in patients with advanced solid tumors | Phase 1 | Los Angeles, California and 11 other locations | Recruiting | Feb 5, 2024 |
| Testing JANX007 for advanced prostate cancer | Phase 1 | Birmingham, Alabama and 37 other locations | Recruiting | Aug 29, 2022 |
| Using omeprazole to enhance treatment for advanced prostate cancer | Phase 2 | Salisbury, North Carolina and 1 other locations | Recruiting | Apr 7, 2020 |
| New bispecific antibody treatment for advanced prostate cancer | Phase 1 | Tübingen, Baden-Wurttemberg and 1 other locations | Recruiting | Sep 26, 2019 |
All recruiting trials (5)
-
Ifinatamab deruxtecan alone or with other drugs for metastatic castration‑resistant prostate cancer
This trial tests whether ifinatamab deruxtecan, given alone or with other cancer drugs, helps men with metastatic castration‑resistant prostate cancer by lowering PSA and controlling disease.
-
Testing MGC026 in patients with advanced solid tumors
This study is testing a new treatment called MGC026 to see if it can help adults with advanced solid tumors that can't be removed or have spread to other parts of the body.
-
Testing JANX007 for advanced prostate cancer
This study is testing a new treatment called JANX007 combined with Darolutamide to see if it helps adults with advanced prostate cancer who haven't responded to other therapies.
-
Using omeprazole to enhance treatment for advanced prostate cancer
This study is testing if adding omeprazole to taxane treatments can help men with advanced prostate cancer who haven't responded to these therapies before.
-
New bispecific antibody treatment for advanced prostate cancer
This study is testing a new treatment for advanced prostate cancer to see if a special antibody can help patients whose cancer hasn't responded to other therapies.
Related topics
Quick answers
How many Castration Resistant Prostatic Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in United States (4 trials), Australia (3 trials), United Kingdom (2 trials), Germany (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.